Large studies have demonstrated associations between circulating levels of IL-6 and risk of ASCVD events, independent of traditional ASCVD risk factors.25,26 A meta-analysis confirmed that higher plasma IL-6 levels are significantly linked to a greater risk of future non-fatal MI or fatal coronary heart disease. Here, IL6 is linked to coronary artery disorder.